Özet:

Objective: In this study, we aimed to determine the clinical and epidemiological features of lung cancer patients, treatment modalities, survival and factors affecting survival in the patients who were followed up at our clinic retrospectively. Material and Method: Ninety two non-small cell lung cancer patients who were referred to the University of New York University, Department of Medical Oncology Clinic between January 2012-May 2016 were included in the study. Results: 81 patients were male (88%) and 11 females (12%),that average age was 65.3±8.99 years. 86.6% of the patients are active smokers. At the time of diagnosis 94.5% of patients were ECOG 0-1 performance status. For histopathologic subgroups, 47 (51.1%) adenocarsinomo, 39 (42.4%) were squuamouscell carcinoma, 6 (6. 5%) other NSCLC subtypes. The presence of lymphovascular invasion is compared with tumor types, lymphovascular invasion have observed in 62.5% (n=5) of adenocarcinoma, 37.5% (n=3) of squamous cell carcinoma. In the 29.6% (n=8) of the cases, there was lymphovascular invasion but the lymphovascular invasion have not been observed in the majority of the patients (%70.4, n=19). Median survival was 23.4 months in males, 18.1 months in women (p= 0.63). The survival was effected by lymphovascular invasion, ECOG performance status and cancer stage but not by age, sex, co-morbidity, smoking, cancer type, treating with chemotherapy, existing brain metastasis. Conclusions: In conclusion, our study evaluates clinical, histological, survival features and factors affecting survival in non-small cell lung cancer patients who were followed up at our clinic.

Anahtar Kelimeler: